阿尔茨海默病记忆障碍的基础实验模型研究
Basic Experimental Model of Memory Impairment in Alzheimer’s Disease
DOI: 10.12677/OJNS.2023.116110, PDF,    科研立项经费支持
作者: 胡祥烽, 丁洁莹, 车土玲:宁德师范学院医学院,福建 宁德;林 俊:海南医学院临床学院,海南 海口;苏裕盛*:宁德师范学院医学院,福建 宁德;宁德师范学院毒物与药物毒理学重点实验室,福建 宁德
关键词: 阿尔茨海默病记忆障碍模型研究Alzheimer’s Disease Memory Disorder Model Study
摘要: 阿尔茨海默病(Alzheimer’s disease,AD)是具有复杂病理特征的疾病,AD在病情发展过程中会对患者脑部造成不可逆的损害而导致记忆障碍,记忆缺失对正常生活有着影响,而且AD多发于老年人群体。对于日益加剧的人口老龄化现象,存在着极大的风险隐患。进行尸检样本的解剖研究对现阶段研究AD已经十分局限,进行动物模型研究可以寻求新突破口,在实验室中,可以通过细胞离体培养、转基因动物、特定环境设置、手术处理改变特定物质分泌等手段,直接明了地观测受试动物机体中各种有关物质的变化,例如淀粉样蛋白、神经原纤维缠结、γ分泌酶、炎症因子等与AD相关的物质的活性与水平,为后续开展针对性治疗奠定理论基础。此外,这些实验模型研究可帮助更好地理解该疾病的病理学机制,并为临床治疗提供思路。
Abstract: Alzheimer’s disease (AD) is a disease with complex pathological characteristics, AD will cause irreversible damage to the patient’s brain during the development of the disease, resulting in memory impairment, memory loss has an impact on normal life, and AD is more common in the elderly. For the increasingly aging population phenomenon, there are great risks and hidden dangers. The anatomical study of autopsy samples has been very limited to the current research on AD, and the study of animal models can seek a new breakthrough. In the laboratory, the changes of various related substances in the body of tested animals can be directly and clearly observed by means of cell culture in vitro, transgenic animals, specific environmental settings, and surgical treatment to change the secretion of specific substances. For example, the activity and level of amyloid protein, neurofibrillary tangles, gamma secretase, inflammatory factors and other substances related to AD lay a theoretical foundation for subsequent targeted treatment. In addition, these experimental model studies can help better understand the pathological mechanisms of the disease and provide ideas for clinical treatment.
文章引用:胡祥烽, 丁洁莹, 车土玲, 林俊, 苏裕盛. 阿尔茨海默病记忆障碍的基础实验模型研究[J]. 自然科学, 2023, 11(6): 917-925. https://doi.org/10.12677/OJNS.2023.116110

参考文献

[1] Qiu, S., Miller, M.I., Joshi, P.S., et al. (2022) Multimodal Deep Learning for Alzheimer’s Disease Dementia As-sessment. Nature Communications, 13, Article No. 3404. [Google Scholar] [CrossRef] [PubMed]
[2] Jorfi, M., Maaser-Hecker, A. and Tanzi, R.E. (2023) The Neuroimmune Axis of Alzheimer’s Disease. Genome Medicine, 15, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[3] Tahami, M.A., Byrnes, M.J., White, L.A., et al. (2022) Alzheimer’s Disease: Epidemiology and Clinical Progression. Neurology and Therapy, 11, 553-569. [Google Scholar] [CrossRef] [PubMed]
[4] Chang, C.H., Lin, C.H. and Lane, H.Y. (2021) Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease. International Journal of Molecular Sciences, 22, Article 2761. [Google Scholar] [CrossRef] [PubMed]
[5] Dubois, B., Villain, N., Frisoni, G.B., et al. (2021) Clinical Diag-nosis of Alzheimer’s Disease: Recommendations of the International Working Group. The Lancet Neurology, 20, 484-496. [Google Scholar] [CrossRef
[6] Athar, T., Al, B.K. and Khan, S.A. (2021) Recent Ad-vances on Drug Development and Emerging Therapeutic Agents for Alzheimer’s Disease. Molecular Biology Re-ports, 48, 5629-5645. [Google Scholar] [CrossRef] [PubMed]
[7] Ling, T.S., Chandrasegaran, S., Xuan, L.Z., et al. (2021) The Potential Benefits of Nanotechnology in Treating Alzheimer’s Disease. BioMed Research International, 2021, Article ID: 5550938. [Google Scholar] [CrossRef] [PubMed]
[8] Hanslik, K.L. and Ul-land, T.K. (2020) The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer’s Disease. Frontiers in Neu-rology, 11, Article ID: 570711. [Google Scholar] [CrossRef] [PubMed]
[9] Gerrits, E., Brouwer, N., Kooistra, S.M., et al. (2021) Distinct Amyloid-β and Tau-Associated Microglia Profiles in Alzheimer’s Disease. Acta Neuropathologica, 141, 681-696. [Google Scholar] [CrossRef] [PubMed]
[10] Huang, L., Peng, Y., Tao, X., et al. (2022) Microtubule Organization Is Essential for Maintaining Cellular Morphology and Function. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 1623181. [Google Scholar] [CrossRef] [PubMed]
[11] Li, S., Wang, C., Wang, Z., et al. (2021) Involvement of Cere-brovascular Abnormalities in the Pathogenesis and Progression of Alzheimer’s Disease: An Adrenergic Approach. Aging, 13, 21791-21806. [Google Scholar] [CrossRef] [PubMed]
[12] Galea, I. (2021) The Blood-Brain Barrier in Systemic Infection and Inflammation. Cellular & Molecular Immunology, 18, 2489-2501. [Google Scholar] [CrossRef] [PubMed]
[13] Alahmari, A. (2021) Blood-Brain Barrier Overview: Struc-tural and Functional Correlation. Neural Plasticity, 2021, Article ID: 6564585. [Google Scholar] [CrossRef] [PubMed]
[14] Banwarth-Kuhn, M. and Sindi, S. (2020) How and Why to Build a Mathematical Model: A Case Study Using Prion Aggregation. Journal of Biological Chemistry, 295, 5022-5035. [Google Scholar] [CrossRef
[15] Cesarino, I., Dello, I.R., Kirschner, G.K., et al. (2020) Plant Science’s Next Top Models. Annals of Botany, 126, 1-23. [Google Scholar] [CrossRef] [PubMed]
[16] Chen, J., Liao, S., Xiao, Z., et al. (2022) The Development and Improvement of Immunodeficient Mice and Humanized Immune System Mouse Models. Frontiers in Immunology, 13, Article ID: 1007579. [Google Scholar] [CrossRef] [PubMed]
[17] 盛哲津, 李利妹. 阿尔茨海默病动物模型的研究进展[J]. 实验动物与比较医学, 2022, 42(4): 342-350.
[18] Ardanaz, C.G., Ramirez, M.J. and Solas, M. (2022) Brain Metabolic Alterations in Alzheimer’s Disease. International Journal of Molecular Sciences, 23, Article 3785. [Google Scholar] [CrossRef] [PubMed]
[19] Bai, B., Vanderwall, D., Li, Y., et al. (2021) Proteomic Landscape of Alzheimer’s Disease: Novel Insights into Pathogenesis and Biomarker Discovery. Molecular Neurodegeneration, 16, Article No. 55. [Google Scholar] [CrossRef] [PubMed]
[20] Tracy, T.E., Madero-Perez, J., Swaney, D.L., et al. (2022) Tau Interactome Maps Synaptic and Mitochondrial Processes Associated with Neurodegeneration. Cell, 185, 712-728. [Google Scholar] [CrossRef] [PubMed]
[21] Sarraf, S.A., Shah, H.V., Kanfer, G., et al. (2020) Loss of TAX1BP1-Directed Autophagy Results in Protein Aggregate Accumulation in the Brain. Molecular Cell, 80, 779-795. [Google Scholar] [CrossRef] [PubMed]
[22] Durkee, C., Kofuji, P., Navarrete, M., et al. (2021) Astrocyte and Neuron Cooperation in Long-Term Depression. Trends in Neurosciences, 44, 837-848. [Google Scholar] [CrossRef] [PubMed]
[23] Mishra, R., Phan, T., Kumar, P., et al. (2022) Augmenting Neurogenesis Rescues Memory Impairments in Alzheimer’s Disease by Restoring the Memory-Storing Neurons. Journal of Experimental Medicine, 219, e20220391. [Google Scholar] [CrossRef] [PubMed]
[24] Forner, S., Kawauchi, S., Balderrama-Gutierrez, G., et al. (2021) Systematic Phenotyping and Characterization of the 5xFAD Mouse Model of Alzheimer’s Disease. Scientific Data, 8, Article No. 270. [Google Scholar] [CrossRef] [PubMed]
[25] Sanchez-Varo, R., Mejias-Ortega, M., Fernan-dez-Valenzuela, J.J., et al. (2022) Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis. In-ternational Journal of Molecular Sciences, 23, Article 5404. [Google Scholar] [CrossRef] [PubMed]
[26] Lopez-Toledo, G., Silva-Lucero, M.D., Herrera-Diaz, J., et al. (2022) Patient-Derived Fibroblasts with Presenilin-1 Mutations, That Model Aspects of Alzheimer’s Disease Pa-thology, Constitute a Potential Object for Early Diagnosis. Frontiers in Aging Neuroscience, 14, Article ID: 921573.
[27] Arber, C., Lovejoy, C., Harris, L., et al. (2021) Familial Alzheimer’s Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis. Cell Reports, 34, Article ID: 108615. [Google Scholar] [CrossRef] [PubMed]
[28] Endres, K. (2021) Apolipoprotein A1, the Neglected Rela-tive of Apolipoprotein E and Its Potential role in Alzheimer’s Disease. Neural Regeneration Research, 16, 2141-2148. [Google Scholar] [CrossRef] [PubMed]
[29] Pires, M. and Rego, A.C. (2023) Apoe4 and Alzheimer’s Disease Pathogenesis-Mitochondrial Deregulation and Targeted Therapeutic Strategies. International Journal of Molecular Sciences, 24, Article 778. [Google Scholar] [CrossRef] [PubMed]
[30] Sierksma, A., Lu, A., Mancuso, R., et al. (2020) Novel Alzheimer Risk Genes Determine the Microglia Response to Amyloid-β But Not to TAU Pathology. EMBO Molecular Medicine, 12, e10606. [Google Scholar] [CrossRef] [PubMed]
[31] Ittner, L.M., Klugmann, M. and Ke, Y.D. (2019) Adeno-Associated Virus-Based Alzheimer’s Disease Mouse Models and Potential New Therapeutic Avenues. British Journal of Pharmacology, 176, 3649-3665. [Google Scholar] [CrossRef] [PubMed]
[32] Sanchez-Hidalgo, A.C., Arias-Aragon, F., Romero-Barragan, M.T., et al. (2022) Selective Expression of the Neurexin Substrate for Presenilin in the Adult Forebrain Causes Deficits in Associative Memory and Presynaptic Plasticity. Experimental Neurology, 347, Article ID: 113896. [Google Scholar] [CrossRef] [PubMed]
[33] Hernandez-Sapiens, M.A., Reza-Zaldivar, E.E., Marquez-Aguirre, A.L., et al. (2022) Presenilin Mutations and Their Impact on Neuronal Differentiation in Alz-heimer’s Disease. Neural Regeneration Research, 17, 31-37. [Google Scholar] [CrossRef] [PubMed]
[34] Pizzo, P., Basso, E., Filadi, R., et al. (2020) Presenilin-2 and Calcium Handling: Molecules, Organelles, Cells and Brain Networks. Cells, 9, Article 2166. [Google Scholar] [CrossRef] [PubMed]
[35] Ledo, J.H., Liebmann, T., Zhang, R., et al. (2021) Presenilin 1 Phosphorylation Regulates Amyloid-Beta Degradation by Microglia. Molecular Psychiatry, 26, 5620-5635. [Google Scholar] [CrossRef] [PubMed]
[36] Galla, L., Redolfi, N., Pozzan, T., et al. (2020) Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2. International Journal of Molecular Sciences, 21, Article 770. [Google Scholar] [CrossRef] [PubMed]
[37] Huang, D.X., Yu, X., Yu, W.J., et al. (2022) Calcium Signaling Regulated by Cellular Membrane Systems and Calcium Homeostasis Perturbed in Alzheimer’s Disease. Frontiers in Cell and Developmental Biology, 10, Article ID: 834962. [Google Scholar] [CrossRef] [PubMed]
[38] Mahan, T.E., Wang, C., Bao, X., et al. (2022) Selective Re-duction of Astrocyte apoE3 and apoE4 Strongly Reduces Aβ Accumulation and Plaque-Related Pathology in a Mouse Model of Amyloidosis. Mol Neurodegener, 17, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[39] Kothari, S., Bala, N., Patel, A.B., et al. (2021) The LDL Receptor Binding Domain of Apolipoprotein E Directs the Relative Orientation of Its C-Terminal Segment in Re-constituted Nascent HDL. Biochimica et Biophysica Acta, 1863, Article ID: 183618. [Google Scholar] [CrossRef] [PubMed]
[40] Tachibana, M., Holm, M.L., Liu, C.C., et al. (2019) APOE4-Mediated Amyloid-Beta Pathology Depends on Its Neuronal Receptor LRP1. Journal of Clinical Investi-gation, 129, 1272-1277. [Google Scholar] [CrossRef
[41] Okazawa, H. (2021) Intracellular Amyloid Hypothesis for Ultra-Early Phase Pathology of Alzheimer’s Disease. Neuropathology, 41, 93-98. [Google Scholar] [CrossRef] [PubMed]
[42] Zhang, C., Xue, P., Zhang, H., et al. (2022) Gut Brain Interaction Theory Reveals Gut Microbiota Mediated Neurogenesis and Traditional Chinese Medicine Research Strategies. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 1072341. [Google Scholar] [CrossRef] [PubMed]
[43] Zhang, H., Ben, Z.Y., Zhang, H., et al. (2021) Rho Signaling in Synaptic Plasticity, Memory, and Brain Disorders. Frontiers in Cell and Developmental Biology, 9, Article ID: 729076. [Google Scholar] [CrossRef] [PubMed]
[44] Kolesnikova, T.O., Demin, K.A., Costa, F.V., et al. (2022) Towards Zebrafish Models of CNS Channelopathies. International Journal of Molecular Sciences, 23, Ar-ticle 13979. [Google Scholar] [CrossRef] [PubMed]
[45] Rosa, J., Lima, C. and Lopes-Ferreira, M. (2022) Zebrafish Larvae Behavior Models as a Tool for Drug Screenings and Pre-Clinical Trials: A Review. International Journal of Molecular Sciences, 23, Article 6647. [Google Scholar] [CrossRef] [PubMed]
[46] Li, Y., Jia, Z., Zhang, S., et al. (2021) Progress in Gene-Editing Technology of Zebrafish. Biomolecules, 11, Article 1300. [Google Scholar] [CrossRef] [PubMed]
[47] Shenoy, A., Banerjee, M., Upadhya, A., et al. (2022) The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer’s Disease. Frontiers in Behavioral Neuroscience, 16, Article ID: 861155. [Google Scholar] [CrossRef] [PubMed]
[48] Saluja, D., Jhanji, R., Kaushal, S., et al. (2021) Importance of Zebrafish as an Efficient Research Model for the Screening of Novel Therapeutics in Neurological Disorders. CNS & Neurological Disorders, 20, 145-157. [Google Scholar] [CrossRef] [PubMed]
[49] James, D.M., Davidson, E.A., Yanes, J., et al. (2021) The Gut-Brain-Microbiome Axis and Its Link to Autism: Emerging Insights and the Potential of Zebrafish Models. Frontiers in Cell and Developmental Biology, 9, Article ID: 662916. [Google Scholar] [CrossRef] [PubMed]
[50] Espino-Saldana, A.E., Rodriguez-Ortiz, R., Pereida-Jaramillo, E., et al. (2020) Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR. Current Neuropharmacology, 18, 136-152. [Google Scholar] [CrossRef
[51] Cosacak, M.I., Bhattarai, P., De Jager, P.L., et al. (2022) Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer’s Disease. Cells, 11, Article 1807. [Google Scholar] [CrossRef] [PubMed]
[52] Disouky, A. and Lazarov, O. (2021) Adult Hippocampal Neuro-genesis in Alzheimer’s Disease. Progress in Molecular Biology and Translational Science, 177, 137-156. [Google Scholar] [CrossRef] [PubMed]
[53] Siddiqui, T., Bhattarai, P., Popova, S., et al. (2021) KYNA/Ahr Signaling Suppresses Neural Stem Cell Plasticity and Neurogenesis in Adult Zebrafish Model of Alz-heimer’s Disease. Cells, 10, Article 2748. [Google Scholar] [CrossRef] [PubMed]
[54] Bhattarai, P., Cosacak, M.I., Mashkaryan, V., et al. (2020) Neu-ron-Glia Interaction through Serotonin-BDNF-NGFR Axis Enables Regenerative Neurogenesis in Alzheimer’s Model of Adult Zebrafish Brain. PLOS BIOLOGY, 18, e3000585. [Google Scholar] [CrossRef] [PubMed]
[55] Lee, J.G., Cho, H.J., Jeong, Y.M., et al. (2021) Genetic Approaches Using Zebrafish to Study the Microbiota-Gut-Brain Axis in Neurological Disorders. Cells, 10, Article 566. [Google Scholar] [CrossRef] [PubMed]
[56] Murray, E.R., Kemp, M. and Nguyen, T.T. (2022) The Mi-crobiota-Gut-Brain Axis in Alzheimer’s Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions. Archives of Clinical Neuropsychology, 37, 595-607. [Google Scholar] [CrossRef] [PubMed]
[57] Zhang, H., Jiang, X., Ma, L., et al. (2022) Role of Abeta in Alz-heimer’s-Related Synaptic Dysfunction. Frontiers in Cell and Developmental Biology, 10, Article ID: 964075. [Google Scholar] [CrossRef] [PubMed]
[58] Kotova, M.M., Galstyan, D.S., Kolesnikova, T.O., et al. (2023) Understanding CNS Effects of Antimicrobial Drugs Using Zebrafish Models. Veterinary Sciences, 10, Article 96. [Google Scholar] [CrossRef] [PubMed]
[59] Nakamura, T., Fujiwara, K., Saitou, M., et al. (2021) Non-Human Primates as a Model for Human Development. Stem Cell Reports, 16, 1093-1103. [Google Scholar] [CrossRef] [PubMed]
[60] 李乙江, 肖文娴, 赵玲, 等. 灵长类动物在人类神经系统疾病动物模型中的应用[J]. 生物化学与生物物理进展, 2022, 49(5): 849-857.
[61] Tramacere, A. and Iriki, A. (2021) A Novel Mind-Set in Primate Experimentation: Implications for Primate Welfare. Animal Models and Ex-perimental Medicine, 4, 343-350. [Google Scholar] [CrossRef] [PubMed]
[62] Alqot, H.E. and Rylett, R.J. (2023) A Novel Transgenic Mouse Model Expressing Primate-Specific Nuclear Choline Acetyltransferase: Insights into Potential Cholinergic Vulnerability. Scientific Reports, 13, Article No. 3037. [Google Scholar] [CrossRef] [PubMed]
[63] Perez-Cruz, C. and Rodriguez-Callejas, J.D. (2023) The Common Marmoset as a Model of Neurodegeneration. Trends in Neurosciences, 46, 394-409. [Google Scholar] [CrossRef] [PubMed]
[64] Philippens, I. and Langermans, J. (2021) Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer’s Disease. Vaccines, 9, Article 388. [Google Scholar] [CrossRef] [PubMed]